Reports
Sale
Global Sexually Transmitted Diseases Testing Market Size: By Disease Type: Chlamydia, Gonorrhoea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Others; By Device Type: Laboratory Devices, Point of Care (POC) Devices; Regional Analysis; Competitive Landscape; 2024-2032
Global Sexually Transmitted Diseases Testing Market Outlook
The global sexually transmitted diseases testing market size reached a value of approximately USD 102.52 billion in 2023. The market is expected to grow at a CAGR of 5.80% between 2024 and 2032, reaching a value of around USD 169.90 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Sexually transmitted diseases or STDs, also known as venereal diseases, refer to viral, bacterial, and parasitic diseases that are spread by sexual contact. Initial transmission typically takes place in the form of a sexually transmitted infection or STI that later becomes a disease or STD. In initial stages, the disease may be asymptomatic. Sexually transmitted diseases testing refers to the testing processes, procedures, and devices used to identify the presence of an STD and perform diagnostics. STDs may also be spread through non-sexual means, such as sharing of needles, blood transfusions, or from mothers to children during childbirth or pregnancy.
- Over the past few years, STD prevalence and incidence have significantly increased. As the number of cases increases, nations all over the world are focusing on developing national screening programmes to expand the use of testing for sexually transmitted diseases. Policies for funding of diagnostic tests for sexually transmitted diseases have also been helpful. These factors have a significant impact on the growth of the global sexually transmitted disease testing market.
- Increase in initiatives and campaigns by various governments, and rising public awareness of various sexually transmitted diseases are increasing the demand for STD tests and the sexually transmitted diseases testing market. With a growing population of people that are sexually active, more people are opting for regular testing for STDs to protect themselves and partners.
- The development of more advanced testing devices and improvements in treatment strategies are anticipated to increase demand for testing of sexually transmitted diseases and the sexually transmitted diseases (STDs) testing devices market. Availability of novel diagnostics and advancements in testing service infrastructure are resulting in faster and more precise test results, enabling improved treatment of STDs.
Global Sexually Transmitted Diseases Testing Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on disease type, the market is divided into chlamydia, gonorrhoea, herpes simplex virus, syphilis, and human papillomavirus (HPV), among others. The sexually transmitted diseases testing market on the basis of device type is bifurcated into laboratory devices and point of care (POC) devices. Laboratory devices are further segmented into thermal cyclers- PCR, lateral flow readers, flow cytometers, differential light scattering machines, and absorbance microplate reader, among others, while point of care (POC) devices are sub-divided into phone chips (Microfluidics and ICT) and portable/bench top/rapid diagnostic. The regional markets for sexually transmitted diseases testing are divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global sexually transmitted diseases testing market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- bioMérieux SA
- Thermo Fisher Scientific Inc.
- Quidel Corporation
- Hologic, Inc.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A
- QIAGEN GmbH
- Becton, Dickinson and Company
- Others
Market Share by Disease Type
Gonorrhoea is predicted to account for a sizable share of the sexually transmitted diseases testing market during the forecast period. An infection caused by a bacterium, gonorrhoea is one of the most widely prevalent STDs that can be contracted during oral, anal, or vaginal sex with an infected patient. Both men and women can get sick from the infection. In the upcoming years, the market share for gonorrhoea testing will increase due to the rising prevalence of the infection.
Testing for gonorrhoea is crucial because it identifies the existence of the gonorrhoea bacteria in the body so that an effective therapy can be prescribed quickly. Lack of awareness about sexually transmitted diseases and a preference for unprotected sex are increasing the prevalence of gonorrhoea and other STDs, increasing the growth of the sexually transmitted diseases testing market.
Market Share by Region
North America is predicted to dominate the global sexually transmitted diseases testing market due to the rising demand for sexually transmitted diseases diagnostics, accessibility of technologically advanced products, and increasing uptake of point of care testing. The United States is projected to be a key market in the North American region because of the presence of numerous diagnostic firms and increased awareness about STDs among people.
Meanwhile, in the Asia Pacific an increase in STD cases, a growing youth population, lack of awareness, and increasing activities by various governments are driving the Asia Pacific sexually transmitted diseases (std) testing market. Surging initiatives of various governments and greater patient awareness through education campaigns are anticipated to fuel the expansion of the market for sexually transmitted diseases testing in the Asia Pacific in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
F. Hoffmann-La Roche Ltd, founded in 1896 and headquartered in Switzerland is a leading biotech company in the world that provides accurate medications with over 50% of their product pipeline comprising of biopharmaceuticals. The products and services of the company address disease prevention, diagnostics, and treatment to enhance patient wellbeing and quality of life. Their diagnostic specialties include coagulation testing, tissue/haematology/urine diagnostics, and diabetes.
Abbott Laboratories is a leader in worldwide healthcare headquartered in Illinois in the United States. With top brands and products in diagnostics, medical equipment, nutrition, and generic medications, its portfolio of game-changing technology covers the whole range of healthcare. The company, which was established in 1888, is renowned for its diagnostics, medical equipment, food products, and branded generic medications.
Thermo Fisher Scientific Inc., with its headquarters in Massachusetts, United States, is a pioneer in the field of science and healthcare. Thermo Fisher Scientific, established in 1956, equips its customers to make the world a safer, cleaner, and healthier place. To address challenging analytical challenges in research, diagnostics, and clinical laboratories, the company offers medical equipment, reagents and consumables, software, and services, and analytical instruments.
Other market players include bioMérieux SA, Quidel Corporation, Hologic, Inc., Bio-Rad Laboratories, Inc., DiaSorin S.p.A, QIAGEN GmbH, and Becton, Dickinson and Company, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Type |
|
| Breakup by Device Type |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Sexually Transmitted Diseases Testing Market Analysis
8.1 Key Industry Highlights
8.2 Global Sexually Transmitted Diseases Testing Historical Market (2018-2023)
8.3 Global Sexually Transmitted Diseases Testing Market Forecast (2024-2032)
8.4 Global Sexually Transmitted Diseases Testing Market by Disease Type
8.4.1 Chlamydia
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Gonorrhoea
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Herpes Simplex Virus
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 Syphilis
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2023)
8.4.4.3 Forecast Trend (2024-2032)
8.4.5 Human Papillomavirus (HPV)
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2023)
8.4.5.3 Forecast Trend (2024-2032)
8.4.6 Others
8.5 Global Sexually Transmitted Diseases Testing Market by Device Type
8.5.1 Laboratory Devices
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.1.4 Breakup by Type
8.5.1.4.1 Thermal Cyclers- PCR
8.5.1.4.2 Lateral Flow Readers
8.5.1.4.3 Flow Cytometers
8.5.1.4.4 Differential Light Scattering Machines
8.5.1.4.5 Absorbance Microplate Reader
8.5.1.4.6 Others
8.5.2 Point of Care (POC) Devices
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.2.4 Breakup by Type
8.5.2.4.1 Phone Chips (Microfluidics and ICT)
8.5.2.4.2 Portable/Bench Top/Rapid Diagnostic
8.6 Global Sexually Transmitted Diseases Testing Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2023)
8.6.4.3 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2023)
8.6.5.3 Forecast Trend (2024-2032)
9 North America Sexually Transmitted Diseases Testing Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2023)
9.1.3 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2023)
9.2.3 Forecast Trend (2024-2032)
10 Europe Sexually Transmitted Diseases Testing Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2023)
10.1.3 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2023)
10.2.3 Forecast Trend (2024-2032)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2023)
10.3.3 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2023)
10.4.3 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Sexually Transmitted Diseases Testing Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2023)
11.1.3 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2023)
11.2.3 Forecast Trend (2024-2032)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2023)
11.3.3 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2023)
11.4.3 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2023)
11.5.3 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Sexually Transmitted Diseases Testing Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2023)
12.1.3 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2023)
12.2.3 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2023)
12.3.3 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Sexually Transmitted Diseases Testing Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2023)
13.1.3 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2023)
13.2.3 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2023)
13.3.3 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2023)
13.4.3 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 F. Hoffmann-La Roche Ltd
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Abbott Laboratories
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 bioMérieux SA
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Thermo Fisher Scientific Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Quidel Corporation
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Hologic, Inc.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Bio-Rad Laboratories, Inc.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 DiaSorin S.p.A
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 QIAGEN GmbH
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Becton, Dickinson and Company
15.2.10.1 Company Overview
15.2.10.2 Product Portfolio
15.2.10.3 Demographic Reach and Achievements
15.2.10.4 Certifications
15.2.11 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Sexually Transmitted Diseases Testing Market: Key Industry Highlights, 2017 and 2032
2. Global Sexually Transmitted Diseases Testing Historical Market: Breakup by Disease Type (USD Million), 2018-2023
3. Global Sexually Transmitted Diseases Testing Market Forecast: Breakup by Disease Type (USD Million), 2024-2032
4. Global Sexually Transmitted Diseases Testing Historical Market: Breakup by Device Type (USD Million), 2018-2023
5. Global Sexually Transmitted Diseases Testing Market Forecast: Breakup by Device Type (USD Million), 2024-2032
6. Global Sexually Transmitted Diseases Testing Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Sexually Transmitted Diseases Testing Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Sexually Transmitted Diseases Testing Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Sexually Transmitted Diseases Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Sexually Transmitted Diseases Testing Market Structure
Key Questions Answered in the Report
In 2023, the global market for sexually transmitted diseases testing attained a value of approximately USD 102.52 billion.
The market is projected to grow at a CAGR of 5.80% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 169.90 billion by 2032.
The major drivers of the sexually transmitted diseases testing market include growing prevalence and incidence of STDs and increased patient awareness through education campaigns.
An increase in patient check-ups, advancements in testing devices, a shift from traditional laboratory testing to rapid point of care testing, betterment in infrastructure for testing services, and expanding initiatives by various governments are the key trends propelling the growth of the market.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The disease types in the market include chlamydia, gonorrhoea, herpes simplex virus, syphilis, and human papillomavirus (HPV), among others.
HIV, genital herpes, and syphilis are currently diagnosed through blood tests. Swabs of affected areas, inside of the mouth, or sores may also be used in STD testing.
STIs refer to sexually transmitted infections which can worsen and lead to sexually transmitted diseases or STDs.
The major players in the sexually transmitted diseases testing market are F. Hoffmann-La Roche Ltd, Abbott Laboratories, bioMérieux SA, Thermo Fisher Scientific Inc., Quidel Corporation, Hologic, Inc., Bio-Rad Laboratories, Inc., DiaSorin S.p.A, QIAGEN GmbH, and Becton, Dickinson and Company, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER